menu

What to Consider When Testing for Oncogenic Drivers in NSCLC

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

What to Consider When Testing for Oncogenic Drivers in NSCLC

close
What to Consider When Testing for Oncogenic Drivers in NSCLC
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Now that there are more targeted therapies available for metastatic non-small cell lung cancer, what are the best practices for evaluating our patients? Dr. Joshua Bauml elaborates on the opportunities and challenges faced when testing for oncogenic drivers in non-small cell lung cancer.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Now that there are more targeted therapies available for metastatic non-small cell lung cancer, what are the best practices for evaluating our patients? Dr. Joshua Bauml elaborates on the opportunities and challenges faced when testing for oncogenic drivers in non-small cell lung cancer.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 12/2/20